Chromosomal abnormalities and oncogenes

International Journal of Hematology

Volumn 63, Issue 2, 1996, Pages 81-93

  Mitani, Kinuko ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

AML1; MLL; oncogene; transcription factor; translocation

Indexed keywords

TRANSCRIPTION FACTOR;

CHROMOSOME TRANSLOCATION; HUMAN; LEUKEMIA; LYMPHOMA; ONCOGENE; PRIORITY JOURNAL; REVIEW;

EID: 0029919477     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1016/0925-5710(96)00440-9     Document Type: Review

References (74)

1. Nichols J, Nimer SD. Transcription factors, translocations, and leukemia. Blood 1992;80:2953-2963.
2. Rabbitts TH. Chromosomal translocations in human cancer. Nature 1994;372:143-149.
3. (3] Miyoshi H, Kozu T, Shimizu K, et al. The t(8;21) translocation in acute myeloid leukemia results in production of an AML1-MTG8 fusion transcript. EMBO J 1993;12:2715-2721.
4. Nucifora G, Birn DJ, Erickson P, et al. Detection of DNA rearrangements in the AML1 and ETO loci and an AML1/ETO fusion mRNA in patients with t(8;21) acute myeloid leukemia. Blood 1993;81:883-888.
5. Kakizuka A, Miller WH Jr, Umesono K, et al. Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RARα with a novel putative transcription factor, PML. Cell 1991;66:663-674.
6. de The H, Lavau C, Marchio A, et al. The PML-RARα fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell 1991;66:675-684.
7. Tkachuk DC, Kohler S, Cleary ML. Involvement of a homolog of Drosophila trithorax by 11q23 chromosomal translocations in acute leukemias. Cell 1992;71:691-700.
8. Yamamoto K, Seto M, Komatsu H, et al. Two distinct portions of LTG19/ENL at 19p13 are involved in t(11;19) leukemia. Oncogene 1993;8:2617-2625.
9. Morishita K, Parganas E, Willman CL, et al. Activation of EVI1 gene expression in human acute myelogenous leukemias by translocations spanning 300-400 kilobases on chromosome band 3q26. Proc Natl Acad Sci USA 1992;89:3937-3941.
10. Heisterkamp N, Stephenson JR, Groffen J, et al. Localization of the c-abl oncogene adjacent to a translocation break point in chronic myelocytic luekemia. Nature 1983:306:239-242.
11. Konopka JB, Watanabe SM, Witte ON. An alteration of the human C-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activity. Cell 1984;37: 1035-1042.
12. Alimena G, De Cuia MR, Diverio D, Gastaldi R, Nanni, M. The karyotype of blastic crisis. Cancer Genet Cytogenet 1987;26:39-50.
13. Rubin CM, Larson RA, Bitter MA, et al. Association of a chromosomal 3;21 translocation with the blast phase of chronic myelogenous leukemia. Blood 1987;70:1338-1342.
14. Coyle T, Najfeld V. Translocation (3;21) on Philadelphia chromosome-positive chronic myelogenous leukemia prior to the onset of blast crisis. Am J Hematol 1988;27:56-59.
15. Mitani K, Ogawa S, Tanaka T, et al. Generation of the AML1-EVI-I fusion gene in the t(3;21)(q26;q22) causes blastic crisis in chronic myelocytic leukemia. EMBO J 1994;13:504-510.
16. Nourse J, Mellentin JD, Galili N, et al. Chromosomal translocation t(1;19) results in synthesis of a homeobox fusion mRNA that codes for a potential chimeric transcription factor. Cell 1990;60:535-545.
17. Kamps MP, Murre C, Sun X-H, Baltimore D. A new homeobox gene contributes the DNA binding domain of the t(1;19) translocation protein in pre-B ALL. Cell 1990;60:547-555.
18. Inaba T, Roberts WM, Shapiro LH, et al. Fusion of the leucine zipper gene HLF to the E2A gene in human acute B-lineage leukemia. Science 1992;257:531-534.
19. Motokura T, Bloom T, Kim HG, et al. A novel cyclin encoded by a bclo 1-linked candidate oncogene. Nature 1991;350:512-515.
20. Tsujimoto Y, Finger LR, Yunis J, et al. Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation. Science 1984;226: 1097-1099.
21. Vaux DL, Cory S, Adams JM. Bcl-2 gene promotes haematopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 1988;335:440-442.
22. Strasser A, Harris AW, Cory S. bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship. Cell 1991;67:889-899.
23. Rabbitts TH, Boehm T. Structural and functional chimerism results from chromosomal translocation in lymphoid tumors. Adv Immunol 1991;50:119-146.
24. Neri A, Chang C-C, Lombardi L, et al. B cell lymphoma-associated chromosomal translocation involves candidate oncogene lyt-10, homologous to NF-kB p50. Cell 1991;67:1075-1087.
25. Ye BH, Lista F, Lo Coco F, et al. Alterations of a zinc finger-encoding gene, BCL-6, in diffuse large cell-lymphoma. Science 1993;262:747-750.
26. Shima EA, Le Beau MM, Mckeithan TW, et al. Gene encoding the α chain of the T-cell receptor is moved immediately downstream of c-myc in a chromosomal 8;14 translocation in a cell line from a human T-cell leukemia. Proc Natl Acad Sci USA 1986;83:3439-3443.
27. Boehm T, Baer R, Lavenir I, et al. The mechanism of chromosomal translocation t(11;14) involving the T-cell receptor Cδ locus on human chromosome 14q11 and a transcribed region of chromosome 11p15. EMBO J 1988;7:385-394.
28. Boehm T, Lavenir I, Forster A, et al. The T-ALL specific t(11;14)(p13;q11) translocation breakpoint cluster region is located near to the Wilms' tumour predisposition locus. Oncogene 1988;3:691-695.
29. Hatano M, Roberts CWM, Minden M, et al. Deregulation of a homeobox gene, HOX11, by the t(10;14) in T cell leukemia. Science 1991;253:79-82.
30. Chen Q, Cheng J-T, Tsai L-H, et al. The tal gene undergoes chromosome translocation in T-cell leukemia and potentially encodes a helix-loop-helix protein. EMBO J 1990;9:415-424.
31. Burnett RC, David JC, Harden AM, et al. The LCK gene is involved in the t(1;7)(p34;q34) in the T-cell acute lymphoblastic leukemia derived cell line, HSB-2. Genes Chromosomes Cancer 1991;3:461-467.
32. Morris SW, Kirstein MN, Valentine MB, et al. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. Science 1994;263: 1281-1284.
33. Ohno H, Takimoto G, McKeithan TW. The candidate proto-oncogene bcl-3 is related to genes implicated in cell lineage determination and cell cycle control. Cell 1990;60:991-997.
34. Xia Y, Brown L, Yang CY-C, et al. TAL2, a helix-loop-helix gene activated by the t(7;9)(q34;q32) translocation in human T-cell leukemia. Proc Natl Acad Sci USA 1991;88:11416-11420.
35. Mellentin JD, Smith SD, Cleary ML. lyl-1, a novel gene altered by chromosomal translocation in T cell leukemia, codes for a protein with a helix-loop-helix DNA binding motif. Cell 1989;58:77-83.
36. Golub TR, Barker GF, Lovett M, Gilliland DG. Fusion of PDGF receptor β to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation. Cell 1994;77:307-316.
37. Grimaldi JC, Meeker TC. The t(5;14) chromosomal translocation in a case of acute lymphocytic leukemia joins the interleukin-3 gene to the immunoglobulin heavy chain gene. Blood 1989;73:2081-2085.
38. Laabi Y, Gras MP, Carbonnel F, et al. A new gene, BCM, on chromosome 16 is fused to the interleukin 2 gene by a t(4;16)(q26;p13) translocation in a malignant T cell lymphoma. EMBO J 1992;11:3897-3904.
39. Miyoshi H, Shimizu K, Kozu T, et al. t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1. Proc Natl Acad Sci USA 1991;88:10431-10434.
40. Daga A, Tighe JE, Calabi F. Leukaemia/Drosophila homology. Nature 1992;356:484.
41. Bae SC, Yamaguchi-Iwai Y, Ogawa E, et al. Isolation of PEBP2αB cDNA representing the mouse homolog of human acute myeloid leukemia gene, AML1. Oncogene 1993;8:809-814.
42. Ogawa E, Maruyama M, Kagoshima H, et al. PEBP2/PEA2 represents a family of transcription factors homologous to the products of the Drosophila runt gene and the human AML1 gene. Proc Natl Acad Sci USA 1993;90:6859-6863.
43. Nuchprayoon I, Meyers S, Scott LM, et al. PEBP2/CBF, the murine homolog of the human myeloid AML1 and PEBP2β/CBFβ proto-oncoproteins, regulates the murine myeloperoxidase and neutrophil elastase genes in immature myeloid cells. Mol Cell Biol 1994;14:5558-5568.
44. Ogawa E, Inuzuka M, Maruyama M, et al. Molecular cloning and characterization of PEBP2β, the heterodimeric partner of a novel Drosophila runt-related DNA binding protein PEBP2α. Virol 1993;194:314-331.
45. Tanaka T, Tanaka K, Ogawa S, et al. An acute myeloid leukemia gene, AML1, regulates hemopoietic myeloid cell differentiation and transcriptional activation antagonistically by two alternative spliced forms. EMBO J 1995;14:341-350.
46. Miyoshi H, Ohira M, Shimizu K, et al. Alternative splicing and genomic structure of the AML1 gene involved in acute myeloid leukemia. Nucl Acids Res 1995;23: 2762-2769.
47. Satake M, Inuzuka M, Shigesada T, Oikawa T, Ito, Y. Differential expression of subjects of polyomavirus and murine leukemia virus enhancer core binding protein, PEBP2, in various hematopoietic cells. Jpn J Cancer Res 1992;83:714-722.
48. Tanaka K, Tanaka T, Ogawa S, et al. Increased expression of AML1 during retinoic-acid-induced differentiation of U937 cells. Biochem Biophys Res Commun 1995;211:1023-1030.
49. Golub TR, Barker GF, Bohlander SK, et al. Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia. Proc Natl Acad Sci USA 1995;92:4917-4921.
50. Liu P, Tarie SA, Hajra A, et al. Fusion between transcription factor CBFβ/PEBP2β and a myosin heavy chain in acute myeloid leukemia. Science 1993;261: 1041-1044.
51. Rubin CM, Larson RA, Anastasi J, et al. t(3;21)(q26;q22): a recurring chromosomal abnormality in therapy-related myelodysplastic syndrome and acute myeloid leukemia. Blood 1990;76:2594-2598.
52. Morishita K, Parker DS, Mucenski ML, Jenkins NA, Copeland NG, Ihle JN. Retroviral activation of a novel gene encoding a zinc finger protein in IL-3-dependent myeloid leukemia. Cell 1988;54:831-840.
53. Morishita K, Parganas E, Parham DM, Matsugi T, Ihle, JN. The Evi-1 zinc finger myeloid transforming gene is normally expressed in the kidney and in developing oocytes. Oncogene 1990;5:1419-1423.
54. Morishita K, Parganas E, Douglass EC, Ihle JN. Unique expression of the human Evi-1 gene in an endometrial carcinoma cell line: sequence of cDNAs and structure of alternatively spliced transcripts. Oncogene 1990;5: 963-971.
55. Mitani K, Ogawa S, Tanaka T, et al. Growth inhibition of leukaemic cells carrying the t(3;21) by the AML1/EVI-1-specific antisense oligonucleotide. Br J Haematol 1995;90:711-714.
56. Kurokawa M, Ogawa S, Tanaka T, et al. The AML1/Evi-1 fusion protein in the t(3;21) translocation exhibits transforming activity in Rat1 fibroblasts with dependence on the Evi-1 sequence. Oncogene 1995;11:833-840.
57. Tanaka T, Mitani K, Kurokawa M, et al. Dual functions of the AML1/Evi-1 chimeric protein in the mechanism of leukemogenesis in t(3;21) leukemias. Mol Cell Biol 1995;15:2383-2392.
58. Tanaka T, Nishida J, Mitani K, et al. Evi-1 raises AP-1 activity and stimulates c-fos promoter transactivation with dependence on the second zinc finger domain. J Biol Chem 1994;269:24020-24026.
59. Meyer S, Lenny N, Hiebert SW. The t(8;21) fusion protein interferes with AML-1B-dependent transcriptional activation. Mol Cell Biol 1995;15:1974-1982.
60. Liu PP, Hajra A, Wijmenga C, Collins FS. Molecular pathogenesis of the chromosome 16 inversion in the M4Eo subtype of acute myeloid leukemia. Blood 1995;85:2289-2302.
61. Gu Y, Nakamura T, Prasad AR, et al. The t(4;11) chromosome translocation of human acute leukemias fuses the ALL-1 gene, related to Drosophila trithorax, to the AF-4 gene. Cell 1992;71:701-708.
62. Thirman MJ, Gill HJ, Burnett RC, et al. Rearrangement of the MLL gene in acute lymphoblastic and acute myeloid leukemias with 11q23 chromosomal translocations. New Engl J Med 1993;329:909-914.
63. Zeleznik-Le NJ, Harden AM, Rowley JD. 11q23 translocations split the 'AT-hook' cruciform DNA-binding region and the transcriptional repression domain from the activation domain of the mixed-lineage leukemia (MLL) gene. Proc Natl Acad Sci USA 1994;91: 10610-10614.
64. Iida S, Seto M, Yamamoto K, et al. Molecular cloning of 19p13 breakpoint region in infantile leukemia with t(11;19)(q23;p13) translocation. Jpn J Cancer Res 1993;84:532-537.
65. Nakamura T, Alder H, Gu Y, et al. Genes on chromosomes 4, 9, and 19 involved in 11q23 abnormalities in acute leukemia share sequence homology and /or common motifs. Proc Natl Acad Sci USA 1993;90: 4631-4635.
66. Domer PH, Fakharzadeh SS, Chen C-S, et al. Acute mixed-lineage leukemia t(4;11)(q21;q23) generates an MLL-AF4 fusion product. Proc Natl Acad Sci USA 1993;90:7884-7888.
67. Morrissey J, Tkachuk DC, Milatovich A, Francke U, Link M, Cleary ML: A serine/proline-rich protein is fused to HRX in t(4;11) acute leukemias. Blood 1993;81:1124-1131.
68. Iida S, Seto M, Yamamoto K, et al. MLLT3 gene on 9p22 involved in t(9;11) leukemia encodes a serine/proline-rich protein homologous to MLLT1 on 19p13. Oncogene 1993;8:3085-3092.
69. Rubnitz JE, Morrissey J, Savage PA, Cleary ML. ENL, the gene fused with HRX in t(11;19) leukemias, encodes a nuclear protein with transcriptional activation potential in lymphoid and myeloid cells. Blood 1994;84: 1747-1752.
70. Chaplin T, Ayton P, Bernard OA, et al. A novel class of zinc finger/leucine zipper genes identified from the molecular cloning of the t(10;11) translocation in acute leukemia. Blood 1995;85;1435-1441.
71. Prasad R, Leshkowitz D, Gu Y, et al. Leucine-zipper dimerization motif encoded by the AF17 gene fused to ALL-1 (MLL) in acute leukemia. Proc Natl Acad Sci USA 1994;91:8107-8111.
72. Bernard OA, Mauchauffe M, Mecucci C, Van Den Berghe H, Berger, R. A novel gene, AF-1p, fused to HRX in t(1;1)(p32;q23), is not related to AF-4, AF-9 nor ENL. Oncogene 1994;9:1039-1045.
73. Huret JL, Brizard A, Slater R, et al. Cytogenetic heterogeneity in t(11;19) acute leukemia: clinical, hematological and cytogenetic analyses of 48 patients -updated published cases and 16 new observations. Leukemia 1993;7:152-160.
74. Mitani K, Kanda Y, Ogawa S, et al. Cloning of several species of MLL/MEN chimeric cDNAs in myeloid leukemia with t(11;19)(q23;p13.1) translocation. Blood 1995;85:2017-2024.